Cargando…
Effect of Helicobacter pylori-eradication therapy on hepatic steatosis in patients with non-alcoholic fatty liver disease: a randomized–controlled pilot study
BACKGROUND: Helicobacter pylori infection has been associated with insulin resistance and non-alcoholic fatty liver disease (NAFLD). This study was done to evaluate the effect of H. pylori-eradication therapy (HPET) in patients with NAFLD compared to standard management therapy (SMT). METHODS: Eight...
Autores principales: | Maharshi, Vikas, Gupta, Pooja, Kumar, Vijay L, Upadhyay, Ashish Datt, Das, Prasenjit, Yadav, Rajni, Nayak, Baibaswata, Kumar, Ramesh, Shalimar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261206/ https://www.ncbi.nlm.nih.gov/pubmed/32499918 http://dx.doi.org/10.1093/gastro/goz058 |
Ejemplares similares
-
Chronic hepatitis E – an emerging disease in an immunocompromised host
por: Singh, Amitabh, et al.
Publicado: (2018) -
Helicobacter pylori: Eradication or Preservation
por: Sachs, George, et al.
Publicado: (2012) -
Newer agents for Helicobacter pylori eradication
por: Fiorini, Giulia, et al.
Publicado: (2012) -
Recent advances in Helicobacter pylori eradication
por: Niv, Yaron, et al.
Publicado: (2015) -
Helicobacter pylori eradication in the management of glaucoma
por: Ala, Shahram, et al.
Publicado: (2020)